Skip to content

Cardiovascular Risk Markers in Veterans With Post Traumatic Stress Disorder

Cardiovascular Risk Markers in Veterans With PTSD

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01650220
Acronym
CVMarkers
Enrollment
13
Registered
2012-07-26
Start date
2012-04-30
Completion date
2013-01-31
Last updated
2013-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease, Post Traumatic Stress Disorder

Brief summary

This is an observational study designed to determine whether veterans with PTSD have a higher risk of heart disease than those without PTSD. Cardiovascular risk will be assessed by interview and review of medical records, carotid artery ultrasound, and blood tests measuring markers of inflammation. Study participation is approximately 6 months. The eligible study population is veterans of Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF), age 28 through 38 years.

Interventions

None listed

Sponsors

U.S. Army Medical Research and Development Command
CollaboratorFED
INTRuST, Post-Traumatic Stress Disorder - Traumatic Brain Injury Clinical Consortium
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
28 Years to 38 Years
Healthy volunteers
No

Inclusion criteria

* OEF/OIF veterans at the VASDHS * Between 28 and 38 years of age * Willing to complete structured diagnostic interview for PTSD, CIMT ultrasound and blood test * Willing to have a review of their medical records * Able to give informed consent * Have a negative urine pregnancy test, if a woman of child-bearing age

Exclusion criteria

* Do not meet inclusion criteria * History of schizophrenia, other neurocognitive illness (including severe TBI by INTRuST criteria)) or active alcohol and/or drug abuse determined by chart review, interview or AUDIT-C score * Inability to complete study tests within 18 months of study start * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Completion of structured diagnostic interview within 2hrs.12 monthsCompletion of Clinician Assessed PTSD Scale (CAPS), Alcohol Use Disorders Identification Test-Consumption (AUDIT-C), Patient Health Questionnaire-9 (PHQ-9), Pittsburgh Sleep Quality Index (PSQI), INTRuST Uniformed Data Set, and Family History of heart disease, within 2hrs.
Time from CIMT completion to completion of clinical read.18monthsRate of clinical read will help in determining adequate staffing requirements for a larger study.
Completion of serum lab measurements.18months
Recruitment methods feasibility12 monthsComparison of the number of participants per month recruited from medical providers (with/without PTSD) vs. response to recruitment fliers (with/without PTSD) in the first 12 months of the study. Selection bias to be determined by looking at differences in age and co-morbid illnesses.
Ability to schedule Carotid Intima-Media Thickness (CIMT) ultrasound in the Vascular Lab at VA San Diego Healthcare Systems, within 4 months of enrollment18monthsDetermining whether the Vascular Lab has the capacity for a larger clinical study will be informative in planning larger prospective studies.

Secondary

MeasureTime frameDescription
Cardiovascular Disease BiomarkersWithin 6 months of subject recruitmentSerum C-reactive protein and interleukin-6 will be measured
Carotid Intimal Medial Thickness (CIMT) measurementWithin 4 months of subject recruitmentCIMT thickness will be measured by carotid ultrasound

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026